Latest News & Features
Americas
A Los Angeles-based man has pleaded guilty to illegally importing active ingredients used in erectile dysfunction drugs with a value of up to $550,000. 27 March 2017
Americas
A new law on supplementary protection certificates will be implemented on April 1, with the application, prosecution and maintenance of SPCs taking centre stage. José Manuel González
of Clarke, Modet & Co reports. 27 March 2017
Americas
The US Court of Appeals for the Federal Circuit has backed a district court decision that a patent lawsuit against the University of Utah was not exceptional, thereby denying fees to the Max Planck Society for the Advancement of Science. 24 March 2017
Americas
Pfizer has sued Breckenridge Pharmaceutical, Pensa Pharma and Laboratorios del Dr Esteve for patent infringement of its drug Xeljanz. 24 March 2017
Americas
The US Chamber of Commerce has urged the Canadian government to address its ‘promise utility doctrine’, claiming that it “dramatically undermines legal certainty for medical innovators in Canada”. 23 March 2017
Americas
A Biogen patent covering the drug Tecfidera has been upheld by the Patent Trial and Appeal Board, after a challenge from Kyle Bass’s Coalition for Affordable Drugs. 23 March 2017
Big Pharma
The English High Court has ruled that a supplementary protection certificate owned by Merck Sharp & Dohme is invalid because it didn’t comply with European regulations. 23 March 2017
Americas
Sanofi and Regeneron have filed a declaratory judgment of non-infringement claiming that their product Dupixent does not infringe a patent belonging to Amgen. 22 March 2017
Americas
Fluorescent reagent company Biotium has filed a complaint against biotech company Genecopoeia for patent and trademark infringement, as well as unfair competition. 21 March 2017
Americas
The Canadian government has won nearly $5 million in an arbitration claim filed by Eli Lilly which alleged wrongful termination of its drug patents. 21 March 2017